Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
CA 2482244 A1 · Owner: Capua, Ilaria · Inventors: Capua, Ilaria; Cattoli, Giovanni; Marangon, Stefano
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Within the prophylaxis strategies for the control of type A avian influenza caused by viral infection with specific epidemic strain H7N1 a vaccination , process is envisaged comprising the preparation of a heterologous vaccine that is administered to an animal population said vaccine featuring the same , subtype of viral haemoagglutinin HA7 and a different subtype of neuroaminidase NA3, and thereafter detecting the viralinfection positiveness by contacting an antigen with at least one genomic sequence that codes for a neuroaminidase NA1 protein with the biological fluids collected from the animals. By subsequently revealing an antigen-antibody reaction by means of a test for detecting …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 12, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.